Tetrathiafulvalene Radical Cation Dimerization
FULL PAPER
Synthesis of 4: A solution of TsCl (37 mg, 0.20 mmol) in CH2Cl2 (2 mL)
was added dropwise with stirring to a solution of 3 (100 mg, 0.13 mmol),
Et3N (0.05 mL, 0.39 mmol), and DMAP (5 mg) in CH2Cl2 (20 mL) at
08C. The reaction mixture was then stirred for 16 h at RT. After removal
of the solvent, the residue was purified by column chromatography
(SiO2: CH2Cl2/EtOH 99:1) to give the tosylate 4 as a yellow oil (100 mg,
85%). 1H NMR (500 MHz, CD2Cl2): d=7.91 (dd, J=8.4, 4.7 Hz, 2H),
7.36 (d, J=8.4 Hz, 2H), 7.44–7.38 (m, 4H), 6.91 (d, J=7.7 Hz, 2H), 6.24
(s, 2H), 4.67 (t, J=3.5 Hz, 1H), 4.33 (m, 6H), 4.25 (brs, 2H), 4.16 (m,
2H), 4.00 (m, 4H), 3.86–3.46 (m, 15H), 2.43 (s, 3H), 1.79–1.48 ppm (m,
7H); 13C NMR (125 MHz, CD2Cl2): d=154.8, 154.7, 145.5, 135.1, 135.0,
134.9, 134.8, 133.3, 130.3, 128.3, 127.1 (2), 125.6, 125.5, 116.8, 116.7
(2), 116.6, 114.8, 114.7, 110.9 (2), 110.7, 106.1, 106.0, 99.3, 71.3, 71.2,
71.0, 70.2, 70.1, 69.9, 69.8, 69.7, 69.0, 68.6 (2), 68.5 (3), 68.4, 67.1, 62.5,
31.0, 25.9, 21.8, 19.9 ppm;[24] HRMS (HR-TOF): m/z calcd for
C42H52O12S5: 908.2062; found: 908.2056.
106.0 (2), 71.2, 70.9, 70.6, 70.1, 70.0 (2), 69.8, 69.7, 68.5 (2), 68.4,
68.3, 67.7, 51.2, 50.9 ppm;[24] MS (ESI): m/z calcd for C110H123N9O24S12
:
2337.53; found: 2337.37.
Synthesis of 8: A solution of 2,6-diisopropylphenol (0.48 mL, 2.7 mmol),
propargyl bromide (1.2 mL, 8.1 mmol), and K2CO3 (1.1 g, 8.1 mmol) in
dry DMF (10 mL) was heated at 808C for 1 d. After removal of the sol-
vent, the residue was extracted with CH2Cl2 (320 mL) and dried
(MgSO4). After removal of the solvent, the residue was purified by
column chromatography (SiO2: hexane/EtOH 97:3) to give 8 as yellow
oil (50 mg, 86%). 1H NMR (500 MHz, CDCl3): d=7.12 (brs, 3H), 3.40,
(m, 2H), 2.57 (s, 2H), 1.25 ppm (d, J=6.8 Hz, 9H); 13C NMR (125 MHz,
CD2Cl2): d=153.0, 142.2, 125.5, 124.4, 79.5, 75.4, 62.2, 26.9. 24.4 ppm; MS
(GC-MS): m/z (%): 216 , (20%) [M+], 173 (100), 159 (65), 135 (95), 107
(95), 91 (55), 43 (65).
Synthesis of 1·12PF6: The triazide 7 (50 mg, 0.021 mmol), CBPQT·4PF6
(74 mg, 0.066 mmol), and the propargyl ether 8 (15 mg, 0.069 mmol) were
dissolved in DMF (0.5 mL) at RT to afford a deep green solution. Stock
solutions of CuSO4·5H2O in DMF (20 mL, 0.006mm) and ascorbic acid in
DMF (20 mL, 0.012mm) were added. The solution was stirred at RT for
48 h. The crude product, obtained after the removal of the solvent, was
purified by column chromatography (SiO2: Me2CO followed by a 1%
w/v NH4PF6 solution in Me2CO). The green compound present in this
salt solution was concentrated to a small volume and the pure product
was precipitated from this concentrate by adding an excess of cold water.
The bistable tripodal [4]rotaxane 1·12PF6 was isolated as a green solid
Synthesis of 6: A solution of 4 (2.04 g, 2.24 mmol), compound 5 (0.21 mg,
6.7 mmol), and CsCO3 (4.38 g, 13.44 mmol) in dry DMF (50 mL) was
heated at 808C for 1 d. After cooling to RT, the reaction mixture was fil-
tered and the residue was washed with MeCN (20 mL). The combined or-
ganic solution was concentrated in vacuo to obtain the crude THP-pro-
tected compound as a yellow oil, which was redissolved in MeOH/
CH2Cl2 (1:1, 100 mL). A concentrated aqueous solution of HCl (0.5 mL)
was added and the reaction mixture was stirred at RT for 1 h. A 1n
aqueous solution of NaOH (100 mL) was added to the reaction mixture,
which was extracted with CH2Cl2 (3100 mL) and dried (MgSO4). After
removal of the solvent, the residue was purified by column chromatogra-
phy (SiO2: CH2Cl2/EtOH 99:1) to give the triol 6 as a yellow oil (879 mg,
52%). 1H NMR (500 MHz, CD2Cl2): d=7.84 (t, J=8.0 Hz, 6H), 7.36 (t,
J=8.0 Hz, 6H), 6.97 (d, J=8.0 Hz, 6H), 6.86 (d, J=7.9 Hz, 6H), 6.78 (d,
J=7.9 Hz, 6H), 6.24, 6.22, 6.20, 6.19 (4s, 6H; TTF), 4.27 (m, 24H), 4.06
(m, 6H), 3.95 (m, 12H), 3.78–3.58 (m, 42H), 2.07 ppm (s, 3H); 13C NMR
(125 MHz, CD2Cl2): d=156.7, 154.2, 154.1, 152.4, 143.1, 134.5 (2), 134.4
(2), 129.4, 126.5 (2), 125.1, 125.0, 116.2, 116.1 (2), 116.0, 114.3, 114.1,
113.5, 105.6, 72.6, 70.7, 70.5, 69.6, 69.5 (2), 69.3 (2), 68.0 (brs), 67.9,
1
(52 mg, 40%). M.p. 1408C (dec); H NMR (500 MHz, CD3CN): d=9.31–
9.11 (m, 24H), 8.53–8.32 (m, 6H), 8.20–8.00 (m, 18H), 7.09–7.54 (m,
24H), 7.48–7.40 (m, 4H), 7.22 (m, 2H), 7.14–7.10 (m, 6H), 6.91–6.71 (m,
8H), 6.64 (brs, 5H), 6.50–6.40 (m, 3H), 6.33 (s, 1H), 6.28–6.19 (m, 4H),
6.14–6.03 (m, 4H), 5.99–5.93 (m, 4H), 5.82–5.80 (m, 4H), 5.72–5.68 (m,
4H), 4.95–4.85 (m, 6H), 4.56 (brs, 4H), 4.56–4.21 (m, 14H), 4.21–3.79
(m, 60), 3.45 (m, 6H), 3.15 (4H), 2.22 (s, 3H), 1.17–1.13 ppm (m, 36);
MS (ESI): m/z: 1950 [MÀ3PF6]3+, 1427 [MÀ4PF6]4+, 1113 [MÀ5PF6]5+
,
903 [MÀ6PF6]6+, 753 [MÀ7PF6]7+; HRMS (HR-ESI): m/z calcd for
C263H279F54N21O27P9S12: 1950.4843; found: 1950.4875 [MÀ3PF6]3+
.
67.8, 67.3, 61.5, 50.9, 29.9 ppm;[24] MS (ESI): m/z calcd for C110H126O27S12
:
Synthesis of 2: The triazide 7 (50 mg, 0.021 mmol) and the propargyl
ether 8 (15 mg, 0.069 mmol) were dissolved in DMF (1.0 mL) at RT.
Stock solutions of CuSO4·5H2O in DMF (100 mL, 0.006m) and ascorbic
acid in DMF (100 mL, 0.012m) were added. The solution was stirred at
RT for 2 d. After removal of the solvent, the residue was extracted with
CH2Cl2 (310 mL) and dried (MgSO4). After removal of the solvent, the
residue was purified by column chromatography (SiO2: CH2Cl2/EtOH
98:2) to give 2 as a yellow oil (40.6 mg, 65%). 1H NMR (600 MHz,
CD2Cl2): d=7.88 (d, J=8.5 Hz, 2H), 7.84 (s, 1H), 7.81 (d, J=8.5 Hz,
2H), 7.38 (m, 6H), 7.14 (s, 9H), 7.00 (d, J=8.0 Hz, 6H), 6.89 (d, J=
7.0 Hz, 6H), 6.83 (d, J=7.0 Hz, 6H), 6.25, 6.24, 6.23, 6.21 (4s, 6H;
TTF), 4.86 (s, 6H), 4.65 (t, J=4.8 Hz, 6H), 4.29 (m, 21H), 4.15–4.06 (m,
12H), 3.99 (m, 13H), 3.81–3.61 (m, 32H), 3.38 (m, 6H), 2.11 ppm (s,
3H); 13C NMR (150 MHz, CD2Cl2): d=157.2, 154.7, 154.6, 153.3, 144.6,
142.3, 135.0, 134.9, 129.9, 127.0, 126.9, 125.6, 125.5, 125.2, 124.4, 124.1,
116.7, 116.6 (2), 116.5, 114.9, 114.5, 113.9, 110.7, 106.0 (2), 71.2, 71.0,
70.2, 70.1, 70.0, 69.9, 69.8, 68.5, 68.4, 68.3, 68.2 (2), 67.8, 50.8, 30.0, 26.9,
24.1 ppm; MS (MALDI-TOF): m/z calcd for C153H181N9O27S12: 2985.9872;
found: 2985.9567.
2262.51; found: 2262.35.
Synthesis of S3: A solution of TsCl (118 mg, 0.60 mmol) in CH2Cl2
(2 mL) was added dropwise with stirring to a solution of 6 (234 mg,
0.10 mmol), Et3N (0.13 mL, 0.90 mmol), and DMAP (10 mg) in CH2Cl2
(20 mL) at 08C. The reaction mixture was then stirred for 16 h at RT.
After removal of the solvent, the residue was purified by column chroma-
tography (SiO2: CH2Cl2/EtOH 99:1) to give the tritosylate S3 as a yellow
oil (231 mg, 85%). 1H NMR (500 MHz, CD2Cl2): d=7.88 (d, J=8.5 Hz,
3H), 7.82 (d, J=8.5 Hz, 3H), 7.77 (d, J=8.0 Hz, 6H), 7.40 (m, 6H), 7.29
(d, J=8.0 Hz, 6H), 7.01 (d, J=8.5 Hz, 6H), 6.88 (d, J=7.5 Hz, 3H),
6.85–6.81 (m, 9H), 6.23, 6.22, 6.21, 6.19 (4s, 6H; TTF), 4.28 (m, 16H),
4.20 (m, 12H), 4.08 (m, 6H), 3.97 (m, 6H), 3.91 (m, 6H), 3.78 (m, 18H),
3.67–3.61 (m, 20H), 2.10 ppm (s, 3H); 13C NMR (125 MHz, CD2Cl2): d=
157.1, 154.7, 154.6, 145.4, 142.3, 135.0, 134.9 (3), 133.2, 130.2, 129.9,
129.8, 128.1, 127.0, 126.9, 125.6, 125.5, 116.7, 116.6 (2), 116.5, 114.8,
114.6, 114.1, 113.9, 110.7, 106.0 (2), 71.2, 70.9, 70.1 (2), 70.0, 69.9, 69.8
(2), 69.2, 68.3, 68.2, 50.9, 30.9, 21.7 ppm;[24] MS (ESI): m/z calcd for
C
131H144O33S15: 2724.5400; found: 2724.5120.
Synthesis of 7: A solution of tritosylate S3 (230 mg, 0.08 mmol) and NaN3
(82 mg, 1.2 mmol) in dry DMF (20 mL) was heated at 808C for 2 d. After
removal of the solvent, the residue was dissolved in CH2Cl2 (50 mL) and
then washed with a saturated aqueous solution of NH4Cl (230 mL), fol-
lowed by a saturated aqueous solution of K2CO3 (30 mL) and then finally
dried (MgSO4). The crude product, obtained after the removal of the sol-
vent, was purified by column chromatography (SiO2: CH2Cl2/EtOH 99:1)
Acknowledgements
1
to give the triazide 7 as a yellow oil (124 mg, 63%). H NMR (500 MHz,
CD2Cl2): d=7.85 (d, J=8.4 Hz, 6H), 7.37 (t, J=7.7 Hz, 6H), 6.99 (d, J=
8.0 Hz, 6H), 6.89 (d, J=8.0 Hz, 6H), 6.80 (d, J=8.4 Hz, 6H), 6.22, 6.21,
6.20, 6.19 (4s, 6H; TTF), 4.27 (m, 24H), 4.08 (m, 6H), 3.99 (m, 12H),
3.81–3.61 (m, 36H), 3.43 (m, 6H), 2.09 ppm (s, 3H); 13C NMR (125 MHz,
CD2Cl2): d=157.1, 154.7, 154.6, 142.3, 135.0 (2), 134.9 (2), 129.9, 127.0
(2), 125.6, 116.7, 116.6 (2), 116.5, 114.8 (2), 114.7, 113.9, 110.8, 110.7,
This work was supported by the Microelectronics Advanced Research
Corporation (MARCO) and its Focus Center of Functional Engineered
NanoArchitectonics (FENA) and Materials, Structures, and Devices
(MSD), the MolApps Program funded by the Defense Advanced Re-
search Projects Agency (DARPA) and the Center for Nanoscale Innova-
tive Defense (CNID).
Chem. Eur. J. 2008, 14, 3889 – 3895
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3893